Unlabelled: The present investigation was aimed at developing and comparing the cancer-targeting potential of ligand-anchored dendrimers. Folate-, dextran-, and galactose-anchored poly(propylene imine) dendrimers were synthesized and characterized. Dendritic formulations were evaluated for ex vivo cytotoxicity on HeLa and SiHa cell lines. Flow cytometry studies were performed on the HeLa cell line. An ex vivo MTT assay on HeLa cells indicated IC(50) values of 0.05, 0.2, 0.8, and 0.08 μM for folate, dextran, and galactose formulations, and for free paclitaxel (PTX), respectively. An analogous observation was carried out in SiHa cells, where IC(50) values of 0.6, 0.8, 10, and 6 μM were observed by folate, dextran, and galactose formulations, and free PTX, respectively. The outcome of the MTT assay and flow cytometry suggested the order of targeting potential of various ligands under investigation as folate > dextran > galactose. The outcome is deemed to be of scientific value and is believed to assist drug delivery scientists during selection of targeting ligands.
From The Clinical Editor: The cancer targeting potential of folate, dextran and galactose functionalized polypropyleneimine (PPI) dendrimers was studied by this group of investigators, reporting the order of targeting potential as folate > dextran > galactose.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.nano.2010.10.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Folic acid-based hydrogels co-assembled with protocatechuic acid for enhanced treatment of inflammatory bowel disease.
Colloids Surf B Biointerfaces
February 2025
SKL of Marine Food Processing & Safety Control, National Engineering Research Center of Seafood, Collaborative Innovation Center of Seafood Deep Processing, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China. Electronic address:
Inflammatory bowel disease (IBD) presents a significant therapeutic challenge due to the need for oral drug delivery systems that withstand acidic environment of stomach while effectively targeting intestinal inflammation. To address this issue, we created a novel hydrogel system based on a folic acid (FA)-dopamine (DA) conjugate, co-assembled with protocatechuic acid (PCA), to form F-DP hydrogels. These hydrogels demonstrated robust anti-gastric acid, mucosal adhesive, and injectable properties, enhancing their efficacy for targeted delivery.
View Article and Find Full Text PDFCurcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites.
BMC Cancer
September 2024
Jiangxi Provincial Key Laboratory of Prevention and Treatment of Infectious Diseases, Jiangxi Medical Center for Critical Public Health Events, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330052, Jiangxi, P.R. China.
Article Synopsis
- - Curcumin shows potential for preventing and treating colorectal cancer (CRC) by influencing gut microbiota and its metabolites, although its exact mechanisms are not fully understood.
- - In a study with C57BL/6JGpt mice, curcumin treatment improved colon structure, reduced tumor formation, and positively altered gut bacteria diversity compared to CRC mice that did not receive curcumin.
- - The research found that curcumin decreased harmful bacteria and increased beneficial ones, along with identifying 13 metabolites that were altered in the CRC model group, suggesting a significant impact on gut health related to CRC.
Enhanced anti-inflammatory activity of chlorogenic acid via folic acid-TPGS-modified liposomes encapsulation: characterization and evaluation on colitis mice.
Front Pharmacol
August 2024
College of Food Science and Engineering, Jiangxi Agricultural University, Nanchang, China.
Introduction: Chlorogenic acid (CGA) has been identified to possess salient anti-inflammatory, antioxidant, and anticancer attributes. However, its application is limited by its instability and low bioavailability. Liposomes have been considered effective pharmaceutical delivery vehicles due to their ability to continuously release loaded drugs, improve drug stability, and display good biocompatibility.
View Article and Find Full Text PDFInvestigation of Folate-Functionalized Magnetic-Gold Nanoparticles Based Targeted Drug Delivery for Liver: In Vitro, In Vivo and Docking Studies.
ACS Biomater Sci Eng
October 2024
College of Food Sciences, Al-Qasim Green University, Babylon 51013, Iraq.
Article Synopsis
- Magnetic nanoparticles, specifically Au shell-iron core nanoparticles (FeO@Au), were engineered to enhance targeted drug delivery for treating liver cancer by encapsulating curcumin using a dextran coating and functionalizing with folic acid.
- Various analytical techniques confirmed the successful synthesis and characterized the nanoparticles, revealing an average size of 63.3 nm and a negative zeta potential, which suggests good stability.
- In both in vitro and in vivo studies, the nanoparticles demonstrated effective cancer cell death, improved therapeutic outcomes compared to traditional methods, and limited toxicity to healthy cells, indicating their potential as a promising cancer treatment strategy.
Incorporation of CuS nanorods in polyelectrolyte multilayer microcapsules improved cancer cell cytotoxicity and signal intensity in ultrasound imaging.
Int J Pharm
October 2024
Biomaterials Research Laboratory (BMRL), Department of Chemical Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur - 603203, Chengalpattu, Tamil Nadu, India. Electronic address:
The fabrications of hollow microcapsules (MCs) with new architecture and ability to incorporate different nanomaterials have received great interest for targeted cancer therapy. Recently, CuS based nanomaterials have been demonstrated to possess the ability to mimic Fenton-like activity in tumor environment and inducing cancer cell apoptosis by generating highly reactive oxygen species (ROS). In this study, we have developed poly(allylamine) hydrochloride (PAH)/dextran sulfate (DS) polyelectrolyte MCs capable of carrying doxorubicin (DOX) for targeted cancer therapy and ultrasound imaging.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!